| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |